CN103316294B - Be used for the treatment of the pharmaceutical composition of acne - Google Patents

Be used for the treatment of the pharmaceutical composition of acne Download PDF

Info

Publication number
CN103316294B
CN103316294B CN201310230188.4A CN201310230188A CN103316294B CN 103316294 B CN103316294 B CN 103316294B CN 201310230188 A CN201310230188 A CN 201310230188A CN 103316294 B CN103316294 B CN 103316294B
Authority
CN
China
Prior art keywords
parts
acne
treatment
pharmaceutical composition
jianchuan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn - After Issue
Application number
CN201310230188.4A
Other languages
Chinese (zh)
Other versions
CN103316294A (en
Inventor
袁隆洲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qidong Tianfen Electric Tool Technology Innovation Center
Original Assignee
Qidong Tianfen Electric Tool Technology Innovation Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qidong Tianfen Electric Tool Technology Innovation Center filed Critical Qidong Tianfen Electric Tool Technology Innovation Center
Priority to CN201310230188.4A priority Critical patent/CN103316294B/en
Publication of CN103316294A publication Critical patent/CN103316294A/en
Application granted granted Critical
Publication of CN103316294B publication Critical patent/CN103316294B/en
Withdrawn - After Issue legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to the pharmaceutical composition and application thereof that are used for the treatment of acne, be made up of following crude drug: Radix Glycyrrhizae 2-4 part, Radix Paeoniae Alba 2-4 part, Herba Salviae Chinensis 1.5-2 part, Radix Curcumae 1-1.5 part, Cortex Albiziae 1-1.5 part.The invention has the advantages that: provide a kind of new pharmaceutical compositions being used for the treatment of acne, have very remarkable and stable effect for Acne treatment; Flavour of a drug number is less, and is all conventional Chinese medicine, and preparation technology is also very simple, rapid-action, short treating period, and cost is extremely low, greatly reduces the burden of patient; Have no side effect, be suitable for extensive popularization.

Description

用于治疗痤疮的药物组合物Pharmaceutical composition for treating acne

技术领域 technical field

本发明涉及中药技术领域,具体地说,是一种用于治疗痤疮的药物组合物。 The invention relates to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating acne.

背景技术 Background technique

祛痘是运用医学技术或方法消除青春痘的过程;痘是痤疮的俗称,又叫“青春痘”、“暗疮”或“粉刺”,是由于毛囊及皮脂腺阻塞、发炎所引发的一种皮肤病。青春期时,体内的荷尔蒙会刺激毛发生长,促进皮脂腺分泌更多油脂,毛发和皮脂腺因此堆积许多物质,使油脂和细菌附着,引发皮肤红肿的反应。由于这种症状常见于青年男女,所以才称它为“青春痘”。其实,青少年不一定都会长青春痘,而青春痘也不一定只长在青少年的身上。 Acne removal is the process of using medical technology or methods to eliminate acne. Acne is a common name for acne, also known as "acne", "acne" or "acne", which is a skin disease caused by blockage and inflammation of hair follicles and sebaceous glands. . During puberty, the hormones in the body will stimulate hair growth and promote the sebaceous glands to secrete more oil, so the hair and sebaceous glands will accumulate a lot of substances, making the oil and bacteria adhere, causing skin redness and swelling. Because this symptom is common in young men and women, it is called "acne". In fact, not all teenagers will have acne, and acne does not necessarily only occur on teenagers.

目前中西医外用膏药对痤疮的治疗为治标,而内服药中西医治疗的不足是复发率高、不良反应多、治疗费用高,内服药中医治疗痤疮已取得了一定的成效,但现有的药大多偏重单方面,普遍性不强,效果不明显,且药味数较多,治疗周期长,至今尚无一种普遍适用,且能从根本上治愈痤疮的药物。 At present, the external use of traditional Chinese medicine and western medicine plaster is a palliative treatment for acne, and the deficiency of internal medicine Chinese and Western medicine treatment is high recurrence rate, many adverse reactions, and high treatment costs. Internal medicine Chinese medicine treatment of acne has achieved certain results. Most of them lay particular stress on one side, the universality is not strong, the effect is not obvious, and the number of medicine flavors is many, and the treatment cycle is long, so far there is no medicine that is generally applicable and can fundamentally cure acne.

发明内容 Contents of the invention

本发明的目的是针对现有技术中的不足,提供用于治疗痤疮的药物组合物。 The object of the present invention is to provide a pharmaceutical composition for treating acne aiming at the deficiencies in the prior art.

本发明的再一的目的是,提供另一种用于治疗痤疮的药物组合物。 Another object of the present invention is to provide another pharmaceutical composition for treating acne.

本发明的另一的目的是,提供用于治疗痤疮的药物组合物的应用。 Another object of the present invention is to provide the application of the pharmaceutical composition for treating acne.

为实现上述目的,本发明采取的技术方案是:用于治疗痤疮的药物组合物,由以下重量份的原料药制成:甘草2-4份、白芍2-4份、石见穿1.5-2份、郁金1-1.5份、合欢皮1-1.5份。 In order to achieve the above object, the technical solution adopted by the present invention is: a pharmaceutical composition for treating acne, made of the following crude drugs in parts by weight: 2-4 parts of Radix Glycyrrhizae, 2-4 parts of Radix Paeoniae Alba, 1.5-4 parts of Ishijian Chuan 2 parts, 1-1.5 parts of turmeric, 1-1.5 parts of acacia skin.

优选由以下重量份的原料药制成:甘草2份、白芍2份、石见穿1.5份、郁金1份、合欢皮1.5份。 Preferably, it is prepared from the following raw materials by weight: 2 parts of licorice, 2 parts of white peony root, 1.5 parts of Ishimichuan, 1 part of curcuma, and 1.5 parts of bark of Albizia juniperus.

优选由以下重量份的原料药制成:甘草3份、白芍3份、石见穿1.8份、郁金1.2份、合欢皮1.2份。 Preferably, it is prepared from the following raw materials in parts by weight: 3 parts of licorice, 3 parts of white peony root, 1.8 parts of Shi Jianchuan, 1.2 parts of turmeric, and 1.2 parts of bark of Albizia juniperus.

优选由以下重量份的原料药制成:甘草4份、白芍4份、石见穿2份、郁金1.5份、合欢皮1份。 Preferably, it is prepared from the following raw materials in parts by weight: 4 parts of licorice, 4 parts of white peony, 2 parts of Ishimichuan, 1.5 parts of turmeric, and 1 part of bark of Albizia juniper.

为实现上述第二个目的,本发明采取的技术方案是:用于治疗痤疮的药物组合物,由以下重量份的原料药制成:甘草3份、白芍3份、石见穿1.8份、郁金1.2份、合欢皮1.2份、山楂1份、青风藤2份、当归1份、苍术1份、白芷2份、麻黄2份、海藻1.5份、党参2份、白术1份、生地1.5份、三七2份、金荞麦3份。 In order to achieve the above-mentioned second purpose, the technical solution adopted by the present invention is: a pharmaceutical composition for treating acne, made of the following raw materials in parts by weight: 3 parts of Radix Glycyrrhizae, 3 parts of Radix Paeoniae Alba, 1.8 parts of Shi Jianchuan, 1.2 parts of turmeric, 1.2 parts of Albizia juniper, 1 part of hawthorn, 2 parts of Qingfengteng, 1 part of angelica, 1 part of herb, 2 parts of Angelica dahurica, 2 parts of ephedra, 1.5 parts of seaweed, 2 parts of Codonopsis, 1 part of Atractylodes macrocephala, and 1.5 parts of raw land 2 servings, 2 servings of Panax notoginseng, 3 servings of golden buckwheat.

为实现上述第三个目的,本发明采取的技术方案是:所述的药物组合物在制备祛痘药物中的应用。 In order to achieve the third objective above, the technical solution adopted by the present invention is: the application of the pharmaceutical composition in the preparation of acne-removing medicine.

本发明优点在于: The present invention has the advantage that:

1、提供了一种用于治疗痤疮的新药物组合物,对于治疗痤疮有很显著和稳定的效果; 1. A new pharmaceutical composition for treating acne is provided, which has a significant and stable effect on treating acne;

2、药味数较少,且都是常用中药,制备工艺也很简单,起效快,疗程短,成本极低,大大降低了患者的负担; 2. The number of medicinal flavors is small, and they are all commonly used traditional Chinese medicines. The preparation process is also very simple, the effect is fast, the course of treatment is short, and the cost is extremely low, which greatly reduces the burden on patients;

3、无毒副作用,适于广泛推广。 3. It has no toxic and side effects and is suitable for wide promotion.

具体实施方式 Detailed ways

下面结合实施例对本发明提供的具体实施方式作详细说明。 The specific implementation modes provided by the present invention will be described in detail below in conjunction with the examples.

实施例1Example 1

甘草2份、白芍2份、石见穿1.5份、郁金1份、合欢皮1.5份。常规方法煎煮成汤剂。 2 parts of licorice, 2 parts of white peony, 1.5 parts of Shi Jianchuan, 1 part of turmeric, and 1.5 parts of Albizia juniper. The conventional method is decocted into a decoction.

实施例2Example 2

甘草3份、白芍3份、石见穿1.8份、郁金1.2份、合欢皮1.2份。常规方法煎煮成汤剂。 3 parts of licorice, 3 parts of white peony, 1.8 parts of Shi Jianchuan, 1.2 parts of turmeric, and 1.2 parts of Albizia bark. The conventional method is decocted into a decoction.

实施例3Example 3

甘草4份、白芍4份、石见穿2份、郁金1.5份、合欢皮1份。常规方法煎煮成汤剂。 4 parts of licorice, 4 parts of white peony, 2 parts of Shi Jianchuan, 1.5 parts of turmeric, and 1 part of Albizia bark. The conventional method is decocted into a decoction.

实施例4Example 4

甘草2.5份、白芍2.5份、石见穿1.6份、郁金1.3份、合欢皮1.3份。常规方法煎煮成汤剂。 2.5 parts of licorice, 2.5 parts of white peony, 1.6 parts of Shi Jianchuan, 1.3 parts of turmeric, and 1.3 parts of Albizia bark. The conventional method is decocted into a decoction.

实施例5Example 5

甘草3.5份、白芍3.5份、石见穿1.9份、郁金1.3份、合欢皮1.3份。常规方法煎煮成汤剂。 3.5 parts of licorice, 3.5 parts of white peony, 1.9 parts of Shi Jianchuan, 1.3 parts of turmeric, and 1.3 parts of Albizia juniper. The conventional method is decocted into a decoction.

实施例6 临床实验Embodiment 6 clinical experiment

1.病例选择 1. Case selection

面部寻常性痤疮患者60例,具有典型的临床表现,符合寻常性痤疮、青春痘的诊断标准,一个月内未作任何药物治疗,无合并其他疾病。随机分成两组,两组病情、年龄等无显著差异,具有可比性。 60 patients with facial acne vulgaris had typical clinical manifestations, met the diagnostic criteria of acne vulgaris and acne, did not take any drug treatment within one month, and were not associated with other diseases. Randomly divided into two groups, two groups of disease, age, no significant difference, comparable.

试验组:服用按照实施例2制备的中药汤剂(含生药量1.0g/mL),早晚各一次,每次200mL,7天为一个疗程,共服用4个疗程。 Test group: take the traditional Chinese medicine decoction prepared according to Example 2 (containing crude drug content 1.0g/mL), once in the morning and in the evening, 200mL each time, 7 days as a course of treatment, a total of 4 courses of treatment.

对照组:服用按照实施例2方法制备的中药煎煮液(含生药量1.0g/mL),其中中药原料药中不含石见穿,即甘草3份、白芍3份、郁金1.2份、合欢皮1.2份。早晚各一次,每次200mL,7天为一个疗程,共服用4个疗程。 Control group: taking the decoction of traditional Chinese medicine prepared according to the method of Example 2 (containing 1.0 g/mL of crude drug), wherein the raw material of Chinese medicine does not contain Shi Jianchuan, that is, 3 parts of licorice, 3 parts of white peony root, and 1.2 parts of curcuma , 1.2 parts of acacia skin. Once in the morning and evening, 200mL each time, 7 days as a course of treatment, a total of 4 courses of treatment.

2.评价标准 2. Evaluation criteria

显效:颜面部痤疮愈合,无新发红色丘疹,临床症状消失。 Significantly effective: facial acne healed, no new red papules, and clinical symptoms disappeared.

有效:颜面部痤疮基本愈合,无新发红色丘疹,临床症状基本消失。 Effective: facial acne basically healed, no new red papules, and clinical symptoms basically disappeared.

无效:颜面部痤疮及临床症状与治疗前无明显改变,仍有新发红色丘疹。 Ineffective: Facial acne and clinical symptoms have not changed significantly before treatment, and there are still new red papules.

3.疗效结果 3. Efficacy results

见下表1。疗效结果显示,本发明的用于治疗痤疮的药物组合物对痤疮有显著的治疗效果,不但起效快,第1周有效率就达到83.3%,而且治愈率高,治疗4周后更是达到100%的有效率。对照组虽然其他四味药与试验组组成比例相同,但由于没有加入石见穿,疗效大打折扣,治疗4周后有效率才达到43.3%,石见穿在临床上并无治疗痤疮的报道,但本发明的药物组合物疗效显示,石见穿与本发明的其他四味药共用显示了很强的协同作用,使得本发明能够有效的治愈痤疮。两组均未发现不良反应。 See Table 1 below. The curative effect results show that the pharmaceutical composition for treating acne of the present invention has a significant therapeutic effect on acne. Not only does it take effect quickly, but the effective rate reaches 83.3% in the first week, and the cure rate is high. After 4 weeks of treatment, it reaches 83.3%. 100% effective. Although the other four medicines in the control group had the same composition ratio as the test group, the curative effect was greatly reduced because Shi Jianchuan was not added, and the effective rate reached 43.3% after 4 weeks of treatment. There is no clinical report of Shi Jianchuan in treating acne. However, the curative effect of the pharmaceutical composition of the present invention shows that the combination of Shi Jianchuan and other four herbs of the present invention shows a strong synergistic effect, so that the present invention can effectively cure acne. No adverse reactions were found in the two groups.

表1 疗效结果 Table 1 Efficacy results

试验中还分别统计了分别采用实施例1-5的比例的治疗效果,在治疗4周后,有效率分别为91%、100%、92%、85%、80%,结果显示,实施例3的原料药配比治疗效果最好,其次是实施例1和2。 In the test, the therapeutic effects of the proportions of Examples 1-5 were also counted respectively. After 4 weeks of treatment, the effective rates were respectively 91%, 100%, 92%, 85%, and 80%. The results showed that Example 3 The raw material drug ratio therapeutic effect is the best, followed by embodiment 1 and 2.

实施例7Example 7

    发明人在试验过程中,还考察了药味数较多的另一组方,即:甘草3份、白芍3份、石见穿1.8份、郁金1.2份、合欢皮1.2份、山楂1份、青风藤2份、当归1份、苍术1份、白芷2份、麻黄2份、海藻1.5份、党参2份、白术1份、生地1.5份、三七2份、金荞麦3份。服用常规方法制备的中药汤剂(含生药量1.0g/mL),早晚各一次,每次200mL,7天为一个疗程,共服用4个疗程。    In the course of the experiment, the inventor also investigated another group of prescriptions with more medicinal flavors, namely: 3 parts of licorice, 3 parts of white peony, 1.8 parts of Shi Jianchuan, 1.2 parts of turmeric, 1.2 parts of Albizia juniper, and 1 part of hawthorn , Qingfengteng 2 parts, Angelica 1 part, Atractylodes 1 part, Angelica dahurica 2 parts, Ephedra 2 parts, Seaweed 1.5 parts, Codonopsis 2 parts, Atractylodes macrocephala 1 part, Rehmannia 1.5 parts, Panax notoginseng 2 parts, Golden Buckwheat 3 parts. Take traditional Chinese medicine decoction (containing 1.0g/mL of crude drug) prepared by conventional methods, once in the morning and evening, 200mL each time, 7 days as a course of treatment, a total of 4 courses of treatment.

试验结果显示,本中药方剂也能在4周后达到100%的有效率,并且相比实施例2的组方配比,采用前者方剂的患者不仅痤疮得到了治愈,面部疤痕也明显减淡(70%),同时还有部分美白效果(60%),显示这一方剂虽然药味数较多,但不仅具有很好的痤疮治疗效果,还兼有淡化疤痕和美白的效果。 The test results show that this Chinese medicine formula can also achieve 100% effective rate after 4 weeks, and compared with the formula ratio of Example 2, patients who use the former formula not only have their acne cured, but also significantly reduce facial scars ( 70%), and also has some whitening effect (60%), which shows that although this prescription has more medicinal flavors, it not only has a good acne treatment effect, but also has the effect of lightening scars and whitening.

Claims (1)

1.用于治疗痤疮的药物组合物,其特征在于,由以下重量份的原料药制成:甘草3份、白芍3份、石见穿1.8份、郁金1.2份、合欢皮1.2份、山楂1份、青风藤2份、当归1份、苍术1份、白芷2份、麻黄2份、海藻1.5份、党参2份、白术1份、生地1.5份、三七2份、金荞麦3份。 1. The pharmaceutical composition for treating acne is characterized in that it is made of the following crude drugs in parts by weight: 3 parts of Radix Glycyrrhizae, 3 parts of Radix Paeoniae Alba, 1.8 parts of Shi Jianchuan, 1.2 parts of Curcuma, 1.2 parts of Albizia Julibrissin, Hawthorn 1, Qingfengteng 2, Angelica 1, Atractylodes 1, Angelica 2, Ephedra 2, Seaweed 1.5, Codonopsis 2, Atractylodes 1, Rehmannia 1.5, Panax notoginseng 2, Golden buckwheat 3 share.
CN201310230188.4A 2013-06-09 2013-06-09 Be used for the treatment of the pharmaceutical composition of acne Withdrawn - After Issue CN103316294B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310230188.4A CN103316294B (en) 2013-06-09 2013-06-09 Be used for the treatment of the pharmaceutical composition of acne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310230188.4A CN103316294B (en) 2013-06-09 2013-06-09 Be used for the treatment of the pharmaceutical composition of acne

Publications (2)

Publication Number Publication Date
CN103316294A CN103316294A (en) 2013-09-25
CN103316294B true CN103316294B (en) 2015-08-19

Family

ID=49185527

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310230188.4A Withdrawn - After Issue CN103316294B (en) 2013-06-09 2013-06-09 Be used for the treatment of the pharmaceutical composition of acne

Country Status (1)

Country Link
CN (1) CN103316294B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104840509A (en) * 2015-05-28 2015-08-19 李健 Externally applied pharmaceutical composition for treating acne and application thereof

Also Published As

Publication number Publication date
CN103316294A (en) 2013-09-25

Similar Documents

Publication Publication Date Title
CN103393966B (en) A kind of traditional Chinese medicine composition for treating irregular menstruation
CN104491740A (en) Traditional Chinese medicine composition for treating liver cancer and preparation method of traditional Chinese medicine composition
CN101129636A (en) Medicine for treating nasal inflammation
CN103316294B (en) Be used for the treatment of the pharmaceutical composition of acne
CN103330909B (en) A kind of pure Chinese medicine anti-acne medicine
CN103316291B (en) Anti acne of traditional Chinese medicine
CN103520559A (en) Internal herbaceous medicine compound used for treating toothache
CN103316293B (en) A kind of Chinese prescription is for the preparation of the purposes of anti-acne medicine
CN103341111B (en) Traditional Chinese medicine composition for treating spermatorrhea
CN103638193B (en) A kind of Chinese medicine for acne and preparation method thereof
CN102614324A (en) Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis
CN103157069B (en) Miao medicament for treating cholecystitis
CN103006780B (en) Traditional Chinese medicinal composition for treating allergic rhinitis and method for preparing same
CN103860869A (en) Traditional Chinese medicine for treating gestational hypertension
CN103655903A (en) Chinese herba preparation for treating yellow hair
CN101979073A (en) Medicament for soothing liver and regulating Qi
CN102430026A (en) Freckle-removing medicine
CN103330910A (en) Traditional Chinese medicine for preparing acne-removing medicament and healthcare products
CN103316292A (en) Traditional Chinese medicine composition for treatment of acne vulgaris
CN104435979B (en) A kind of medicine for treating rheumatic lumbocrural pain pain
CN100534519C (en) Medicine for treating functional metrorrhagia and preparation method thereof
CN103381247B (en) Traditional Chinese medicinal composition for treating psoriasis
CN103920132A (en) Medicament for treating deficiency of yang of body and preparation method thereof
CN103239689A (en) Chinese medicine preparation for treating chronic cholecystitis
CN101897750A (en) Chinese medicinal preparation for treating breast tuberculosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: QIDONG TIANFEN ELECTRIC TOOL TECHNOLOGY INNOVATION

Free format text: FORMER OWNER: TAICANG SIRUI BIOTECHNOLOGY CO., LTD.

Effective date: 20150702

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Yuan Longzhou

Inventor before: Li Xiuqin

Inventor before: Zhang Hui

Inventor before: Ma Yan

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LI XIUQIN ZHANG HUI MA YAN TO: YUAN LONGZHOU

TA01 Transfer of patent application right

Effective date of registration: 20150702

Address after: Qidong City, Jiangsu province 226200 Nantong lvsigang Tianfen electric tools trade city comprehensive building

Applicant after: QIDONG TIANFEN ELECTRIC TOOL TECHNOLOGY INNOVATION CENTER

Address before: 111, room 8-6, building 2, middle Xingang Road, Taicang Port Development Zone, Suzhou, Jiangsu,

Applicant before: TAICANG SIRUI BIOLOGICAL SCIENCE & TECHNOLOGY CO.,LTD.

C14 Grant of patent or utility model
GR01 Patent grant
AV01 Patent right actively abandoned

Granted publication date: 20150819

Effective date of abandoning: 20250721

AV01 Patent right actively abandoned

Granted publication date: 20150819

Effective date of abandoning: 20250721

AV01 Patent right actively abandoned
AV01 Patent right actively abandoned